Evidence map›Paper›PMID 36673546›Full record

ArticleHealthcare (Basel, Switzerland)2023

Assessment of Knowledge, Stigmatizing Attitudes and Health-Seeking Behaviors Regarding Hepatitis B Virus Infection in a Pharmacy and Community Setting in Sierra Leone: A Cross-Sectional Study.

Manal Ghazzawi, Sahr A Yendewa, Peter B James, Samuel P Massaquoi, Lawrence S Babawo, Foday Sahr, Gibrilla F Deen, Mustapha Kabba, Ponsiano Ocama, Sulaiman Lakoh and 2 more

Abstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Manal GhazzawiKnowHep Foundation, Freetown, Sierra Leone.ORCID 0000-0001-9946-9244
Sahr A YendewaMinistry of Health and Sanitation, Freetown, Sierra Leone.
Peter B JamesFaculty of Health, Southern Cross University, Lismore, NSW 2480, Australia.ORCID 0000-0002-6373-5704
Samuel P MassaquoiMinistry of Health and Sanitation, Freetown, Sierra Leone.
Lawrence S BabawoDepartment of Nursing, School of Community Health Sciences, Njala University, Bo Campus, Freetown, Sierra Leone.ORCID 0000-0002-9292-3325
Foday SahrMinistry of Health and Sanitation, Freetown, Sierra Leone.
Gibrilla F DeenMinistry of Health and Sanitation, Freetown, Sierra Leone.
Mustapha KabbaMinistry of Health and Sanitation, Freetown, Sierra Leone.
Ponsiano OcamaDepartment of Medicine, College of Health Sciences, Makerere University, Kampala P.O. Box 7062, Uganda.
Sulaiman LakohMinistry of Health and Sanitation, Freetown, Sierra Leone.ORCID 0000-0002-7639-0004
Robert A SalataDepartment of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
George A YendewaDepartment of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.ORCID 0000-0002-8474-1812

Funding

Case Clinical Trials Unit: Administrative Supplement NOSI AI-20-031.UM1AI069501 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI George Yendewa · 2012 to 2026
$40.4M
NIH HHS  5UM1AI069501
6 · The paper itself

Abstract

Hepatitis B virus (HBV) is a major global health challenge. Emerging evidence suggests that poor knowledge and stigma are impacting HBV control efforts in sub-Saharan Africa (SSA), but their role is not well understood. We conducted a cross-sectional study of adults aged ≥18 years in a community and pharmacy setting in Freetown, Sierra Leone. A structured questionnaire was used to assess knowledge, stigmatizing attitudes and health-seeking behaviors regarding HBV. Logistic regression was used to identify predictors of HBV knowledge and related stigma. A total of 306 adult participants were enrolled (50.7% male, 7.5% HBV positive and 11.7% vaccinated). Overall, 52.2% had good HBV knowledge and 49.3% expressed a stigmatizing attitude towards people with HBV. Notwithstanding, 72.2% stated they would receive the HBV vaccine if offered, 80.4% would take anti-HBV medication and 78.8% would be willing to attend clinic regularly. Good HBV knowledge was associated with HBV positive status (aOR 4.41; p = 0.029) and being vaccinated against HBV (aOR 3.30; p = 0.034). HBV-related stigma was associated with secondary or higher level of education (aOR 2.36; p < 0.001), good HBV knowledge (aOR 2.05; p = 0.006) and pharmacy setting (aOR 1.74, p = 0.037). These findings suggest that education and stigma reduction may benefit HBV elimination efforts in SSA.

Indexed as

health-seeking behaviorshepatitis B virusknowledgeSierra Leonestigma

Identifiers

PMID36673546
PMCPMC9859485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.